Virology
News
Drugs
Xagena Medicine
Xagena.net
Mechanisms used by viruses to thwart host’s immune defenses
Nevirapine resistance higher than previously thought
Fuzeon plus an active PI provides maximal HIV suppression in treatment-experienced patients
European approval for new Invirase 500 mg tablet for the treatment of HIV
Genetic factor in determining HIV/AIDS risk
Ugandan AIDS study, no evidence of serious violations
FDA has approved Pegasys and Copegus for the treatment of chronic hepatitis C in HIV patients
Peginterferon alfa-2a plus Ribavirin for chronic hepatitis C virus infection in HIV-infected patients
Guidelines on use of Antiretroviral Drugs to prevent HIV infection after sexual, drug use, and accidental exposure
Next Pages
1
[
2
]
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions